The potential neuroprotective effect of nebivolol in a mouse model of MS is partly attributed to the shift of MG towards an M2 phenotype, alleviation of NLRP3 inflammasome activation, and reduction of oxidative stress [98]. The gene discussed is NLRP3; the disease is myeloid sarcoma.